Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Bolaji O. Akala

Name: KEYNOTE-555: pembrolizumab bioavailability after subcutaneous administration in melanoma
Uploaded: 2021-04-07T00:00:00Z
Duration: 7 min 19 s

Sorry, no posts matched your criteria.

Bolaji O. Akala

Cookie settings